Emphasis on Product (Powder and Solvent); Applications (Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small For Gestational Age, Prader-Willi Syndrome, and Others);Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies);Region/Country
The global growth hormone deficiency market is anticipated to grow with an elevated CAGR of around 7% over the forecast period (2022-2028). Human growth hormone, produced by the pituitary gland, spurs growth in children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function. The rising biotechnology industry and increasing demand for specific drugs are catalyzing the market growth of the growth hormone industry. Furthermore, the rising awareness about the severity of the disease and rising incidences of dwarfism is also a responsible factor for the growth of the growth hormone deficiency market. For instance, according to Medline, Achondroplasia is one of the common types of dwarfism. Achondroplasia is a genetic condition that affects about 1 in 15,000 to 1 in 40,000 people. It makes your arms and legs short in comparison to your head and trunk. You may also have a larger head and a weak muscle tone.
Novo Nordisk A/S, Pfizer, Inc, Eli Lilly and Company, Novartis AG, Merck KGaA, Roche, Ferring Pharmaceuticals, Teva Pharmaceutical Industries, Ltd, Ipsen, and Cipla Inc. are some of the prominent players operating in the growth hormone deficiency market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of growth hormone deficiency.
Insights Presented in the Report
“Amongst Product, powder segment holds the major share”
Based on the product, the market is segmented into powder and solvent. The powder segment accounted for a significant market share in 2020 and it is estimated that it will exhibit a higher CAGR during the forecast period. The growth of this segment is mainly due to the higher bioavailability of the lyophilized drugs by the body. Furthermore, the higher stability of the drugs at higher temperatures is also responsible for the growth of the segment in the growth hormone deficiency market.
Amongst Application, the growth hormone deficiency segment holds the major share”
Based on application, the market is divided into growth hormone deficiency, idiopathic short stature, turner syndrome, small for gestational age, Prader-Willi syndrome, and others. The growth hormone deficiency segment grabbed a significant market share in 2020 and is anticipated to grow at a rapid rate in the upcoming years owing to the rising cases of growth hormone deficiency and the frequent product launches for the diseases that are responsible for the segmental growth in the growth hormone deficiency market. For example, in August 2021, SKYTROFA got FDA approval for the treatment of growth hormone deficiency in children.
Amongst Distribution Channel, the online pharmacies segment grow with high CAGR”
Based on distribution channel, the market is divided into retail pharmacies, hospital pharmacies, and online pharmacies. The online pharmacies grabbed a significant market share in 2020 and are anticipated to grow at a rapid rate in the upcoming years. This is due to the rising prevalence of mobile applications and their uses along with an increasing number of startups. For instance, Netmeds was founded in 2015 and reached US$ 1.8 million by 2019. Furthermore, the heavy discounts offered by the online pharmacies attract customers resulting in an increase in the market size of the segment during the forecast period.
“North America represents one of the largest markets of growth hormone deficiency market”
For a better understanding of the market dynamics of the growth hormone deficiency market, a detailed analysis was conducted for different regions across the globe including North America (U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. In 2020, North America has a significant share in the growth hormone deficiency industry. This can be mainly due to the presence of well-established market players and frequent product launches in the region along with affordable health insurance plans in the region enabling the growth of the growth hormone deficiency industry. For instance, the U.S. passed the Affordable care and Reconciliation Acts in which affordable health insurance plans are provided to the people.
Reasons to buy this report:
Customization Options:
The global growth hormone deficiency market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Global Growth Hormone Deficiency Market Covid-19 Impact
6. Global Growth Hormone Deficiency Market Revenue, 2019-2027f
7. Market Insights By Product 7 Market Insights By Product
8. Market Insights By Application
9. Market Insights By Distribution Channel
10. Market Insights By Region
11. Growth Hormone Deficiency Market Dynamics
12. Growth Hormone Deficiency Market Opportunities
13. Growth Hormone Deficiency Market Trends
14. Legal & Regulatory Framework
15. Demand And Supply-side Analysis
16. Value Chain Analysis
17. Competitive Scenario
18. Company Profiled
19. Disclaimer
Research Methodology for the Global Growth Hormone Deficiency Market Analysis (2022-2028)
Analyzing the historical market, estimation of the current market, and forecasting the future market of the global growth hormone deficiency market were the three major steps undertaken to create and analyze the adoption of growth hormone deficiency in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global growth hormone deficiency market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the growth hormone deficiency through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the growth hormone deficiency market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as product, application, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of growth hormone deficiency across the globe.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the growth hormone deficiency. Further, we conducted factor analysis using dependent and independent variables such as the growing number of people with chronic diseases and the increasing elderly population all over the globe. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the growth hormone deficiency sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the growth hormone deficiency market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the growth hormone deficiency market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, application, and distribution channel of the growth hormone deficiency market.
The main objective of the Growth hormone deficiency market Study
The current & future market trends of Growth hormone deficiency were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
